A phase III randomized trial of cisplatin plus vindesine versus cisplatin plus vindesine plus mitomycin C versus cisplatin plus vindesine plus ifosfamide for advanced non-small-cell lung cancer

Respirology

Volumn 1, Issue 1, 1996, Pages 49-54

  Masutani, Masayuki ^a   Akusawa, Hiroshi ^a   Kadota, Astushi ^a   Ohchi, Yasushi ^a   Takahashi, Noriaki ^a   Tanigawa, Satoshi ^a   Koya, Yoshiaki ^a   Horie, Takashi ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Cisplatin; Ifosfamide; Mitomycin C; NSCLC; Randomized trial; Vindesine

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; IFOSFAMIDE; MIPE PROTOCOL; MITOMYCIN; VDA P PROTOCOL; VDA-P PROTOCOL; VEIP PROTOCOL; VINBLASTINE; VINDESINE;

AGED; ANALYSIS OF VARIANCE; ARTICLE; CANCER STAGING; CLINICAL TRIAL; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; PATHOLOGY; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TREATMENT OUTCOME;

AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; FEMALE; HUMANS; IFOSFAMIDE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM STAGING; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINBLASTINE; VINDESINE;

EID: 0030089013     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1843.1996.tb00010.x     Document Type: Article

References (1)

1. Gralla RJ, Casper ES, Kelsen DP et al. Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules. Ann. Intern. Med. 1981; 95: 414-20.